New TB guidelines for persons with HIV.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000517:prevention & control*; D000995:Antitubercular Agents; D002487:Centers for Disease Control and Prevention, U.S.; D000075202:Contraindications; D004347:Drug Interactions; D017408:Guidelines as Topic; D017320:HIV Protease Inhibitors / Q000008:administration & dosage; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage; D012293:Rifampin; D014376:Tuberculosis / Q000188:drug therapy* / Q000517:prevention & control*
D000995:Antitubercular Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D012293:Rifampin